Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glycoprotein L (gL) is an essential viral envelope protein found in all herpesviruses; it forms a tightly associated heterodimer with glycoprotein H (gH), creating the gH/gL complex that controls membrane fusion, a critical step for viral entry into host cells[5][4][8]. Unlike gH, gL lacks a transmembrane region and is necessary for the correct folding, trafficking, and function of gH; together, the complex orchestrates fusion via direct activation of glycoprotein B (gB)[5]. The gH/gL complex also mediates receptor engagement—such as binding integrins for epithelial infection—making gL a target for neutralizing antibodies and fusion-blocking interventions[4][8]. The protein is highly conserved among herpesviruses, with some species-specific differences influencing host tropism and immune targeting[4][5][8]. It is not a human receptor/enzyme, but belongs to the “viral glycoprotein—entry/fusion machinery” molecular class, and as such, is a validated target for antiviral research and mechanistic studies in viral pathogenesis.
Inhibition of the gH/gL/gB complex formation or function; Neutralizing antibody blockade of protein-protein interaction or conformational transition needed for fusion; Blocking interaction with cell surface receptors (e.g., integrins or others)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glycoprotein L (gL).